+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

GRK2 protein-mediated transphosphorylation contributes to loss of function of μ-opioid receptors induced by neuropeptide FF (NPFF2) receptors



GRK2 protein-mediated transphosphorylation contributes to loss of function of μ-opioid receptors induced by neuropeptide FF (NPFF2) receptors



Journal of Biological Chemistry 287(16): 12736-12749



Neuropeptide FF (NPFF) interacts with specific receptors to modulate opioid functions in the central nervous system. On dissociated neurons and neuroblastoma cells (SH-SY5Y) transfected with NPFF receptors, NPFF acts as a functional antagonist of μ-opioid (MOP) receptors by attenuating the opioid-induced inhibition of calcium conductance. In the SH-SY5Y model, MOP and NPFF(2) receptors have been shown to heteromerize. To understand the molecular mechanism involved in the anti-opioid activity of NPFF, we have investigated the phosphorylation status of the MOP receptor using phospho-specific antibody and mass spectrometry. Similarly to direct opioid receptor stimulation, activation of the NPFF(2) receptor by [D-Tyr-1-(NMe)Phe-3]NPFF (1DMe), an analog of NPFF, induced the phosphorylation of Ser-377 of the human MOP receptor. This heterologous phosphorylation was unaffected by inhibition of second messenger-dependent kinases and, contrarily to homologous phosphorylation, was prevented by inactivation of G(i/o) proteins by pertussis toxin. Using siRNA knockdown we could demonstrate that 1DMe-induced Ser-377 cross-phosphorylation and MOP receptor loss of function were mediated by the G protein receptor kinase GRK2. In addition, mass spectrometric analysis revealed that the phosphorylation pattern of MOP receptors was qualitatively similar after treatment with the MOP agonist Tyr-D-Ala-Gly (NMe)-Phe-Gly-ol (DAMGO) or after treatment with the NPFF agonist 1DMe, but the level of multiple phosphorylation was more intense after DAMGO. Finally, NPFF(2) receptor activation was sufficient to recruit β-arrestin2 to the MOP receptor but not to induce its internalization. These data show that NPFF-induced heterologous desensitization of MOP receptor signaling is mediated by GRK2 and could involve transphosphorylation within the heteromeric receptor complex.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053343549

Download citation: RISBibTeXText

PMID: 22375000

DOI: 10.1074/jbc.m111.314617


Related references

Agonist-induced functional desensitization of the mu-opioid receptor is mediated by loss of membrane receptors rather than uncoupling from G protein. Molecular Pharmacology 50(5): 1214-1222, 1996

EGF transregulates opioid receptors through EGFR-mediated GRK2 phosphorylation and activation. Molecular Biology of the Cell 19(7): 2973-2983, 2008

Streptozotocin-induced diabetes selectively reduces antinociception mediated by 1-opioid receptors, but not that mediated by 2-opioid receptors. Neuroscience Letters 165(1-2): 141-143, 1994

Streptozotocin-induced diabetes selectively reduces antinociception mediated by mu 1-opioid receptors, but not that mediated by mu 2-opioid receptors. Neuroscience Letters 165(1-2): 141-143, 1994

Buprenorphine-Induced Antinociception Is Mediated by -Opioid Receptors and Compromised by Concomitant Activation of Opioid Receptor-Like Receptors. The Journal of Neuroscience 23(32): 10331-10337, 2003

Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors. Journal of Neuroscience 23(32): 10331-7, 2003

Pentazocine-Induced Antinociception Is Mediated Mainly by micro-Opioid Receptors and Compromised by kappa-Opioid Receptors in Mice. 2011

Pentazocine-induced antinociception is mediated mainly by μ-opioid receptors and compromised by κ-opioid receptors in mice. Journal of Pharmacology and Experimental Therapeutics 338(2): 579-587, 2011

Opioid-induced increase in [Ca2+]i in ND8-47 neuroblastoma x dorsal root ganglion hybrid cells is mediated through G protein-coupled delta-opioid receptors and desensitized by chronic exposure to opioid. Journal of Neurochemistry 65(4): 1612-1621, 1995

Biochemical anti-opioid action of NPFF2 receptors in rat spinal cord. Neuroscience Research 58(1): 91-94, 2007

Phosphorylation of GRK2 by PKA augments GRK2-mediated phosphorylation, internalization, and desensitization of VPAC2 receptors in smooth muscle. American Journal of Physiology. Cell Physiology 294(2): C477-C487, 2008

Distribution of neuropeptide receptors. New views of peptidergic neurotransmission made possible by antibodies to opioid receptors. Annals of the new York Academy of Sciences 757: 390-404, 1995

Neuropeptide Y-induced contraction is mediated by neuropeptide Y Y2 and Y4 receptors in the rat colon. European Journal of Pharmacology 374(1): 85-91, 1999

Vasodilation in human subcutaneous arteries induced by neuropeptide Y is mediated by neuropeptide Y Y1 receptors and is nitric oxide dependent. Canadian Journal of Physiology and Pharmacology 78(3): 251-255, 2000

Vasodilation in human subcutaneous arteries induced by neuropeptide Y is mediated by neuropeptide Y Y 1 receptors and is nitric oxide dependent. Canadian Journal of Physiology and Pharmacology 78(3): 251-255, 2000